
Case Studies
Communicating Impact with a New Company Name
Industry: Health tech
Engagement Length: <3 mo
-
A small health tech company was formed in 2017 with the mission of improving patient access to diagnostics. Since then it has expanded its technology platform to more holistically help patients and providers develop a clearer picture of costs and prior authorizations for molecular diagnostics. In early 2022, company planned another round of funding to continue its plan to scale. In preparation, they had already updated the look and feel of their brand to reflect a patient centric orientation. They decided that they also needed to update their name to reflect the company's new ambition.
-
THS implemented a comprehensive approach to contribute to the company’s strategic rebranding process. This included synthesizing insights from internal and external stakeholders to inform a robust recommendation for a new company name. The approach was structured around discovery and analysis phases, workshops, and collaborative activities to align on a name that matched the company’s evolving brand and value proposition. THS leveraged an agile, feedback-driven methodology that included diverse stakeholders and validated ideas through primary market research to avoid bias. This thorough and inclusive process culminated in the successful rebranding, which resonated well internally and externally.
-
THS helped the company identify a new name that aligned with its updated brand and value proposition. This agile, inclusive approach engaged diverse stakeholders and garnered nearly universal internal support. The direction was reinforced through primary market research with potential patients, ensuring external validation and reducing internal bias. The process considered 44 potential names, all vetted for alignment with brand values and availability of trademarks and domains.
The positive outcomes included strong market feedback and significant financial success, as evidenced by a successful $17 million Series B funding round in Q2 2022.
Explore how we can deliver similar results for your organization.